Principal Investigator
Carlos Singer
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20260239
Clinical Trial Summary
Phase 2, double-blind, placebo-controlled study to evaluate the effectiveness of two doses of AP-472 as adjunctive therapy to levodopa in Parkinsons disease (PD) participants with motor fluctuations
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Silvia Vargas Parra
Phone Number
+1 (305) 2433647
Email
s.vargasparra@miami.edu